Navigation Links
Exiqon: Major Shareholder Announcement
Date:6/30/2008

VEDBAEK, Denmark, June 30 /PRNewswire-FirstCall/ -- Exiqon A/S today received information from Danske Bank, that the Danske Bank Group - including Danica Pension Livsforsikring and Danske Fund FCP - through acquisition today of 502,300 shares now owns 1,804,514 shares of a nominal value of each DKK 1 corresponding to 5,99% of the share capital and 5,99% of the voting rights in Exiqon A/S.

About Exiqon

Exiqon's corporate mission is to combine leading-edge scientific expertise in gene expression with our proprietary LNA(TM) technology. Exiqon's products, services and scientific staff enable life science researchers to make groundbreaking discoveries. Moreover, Exiqon is addressing the unmet need for a new approach to the diagnosis of cancer. Exiqon's products are based on patented technology (LNA(TM) or Locked Nucleic Acids) that facilitates very precise and sensitive analysis of nucleic acids. Exiqon aims to expand the existing product offering for research use as well as to develop new proprietary molecular diagnostic products. Exiqon, through a number of recent initiatives, has positioned itself as a significant player in applying miRNA as the key biomarker in cancer diagnostics. Exiqon has facilities in Denmark, Boston (MA) and Tustin (CA).

For more information, please contact:

Exiqon A/S,

Lars Kongsbak, President and CEO, tel. +45-40-90-21-01,

Hans Henrik Chrois Christensen, CFO, tel. +45-40-90-2131.


'/>"/>
SOURCE Exiqon
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Palladian Muscular Skeletal Health (formerly Prism Health Networks) to Promote Collaborative, Expanded Practice Model at Major Insurance Conference in June
2. Cord Blood America Reports CorCell, Its Major Acquisition in 2006, Turns Profitable
3. BioElectronics Corporation Receives Major Orders From Italian Distributor
4. deCODE Discovers Fourth Major Set of Common Genetic Variants Linked to Risk of Estrogen Receptor-Positive Breast Cancer
5. Syngenta To Build Major Global Biotech Research Center in Beijing, China
6. Axial Biotech Meets Major Scientific Milestones; Receives $6 Million Tranche of Series B Financing
7. Major EPA enforcement effort on nano-pesticide applauded
8. Cardiac Science Unveils Major Brand Change; Strategy to Lift Brand Awareness
9. Major Medical Journal Reports Higher Success, Fewer Complications and Lower Cost Treating DVT With Trellis(R) Isolated Thrombolysis Compared With Catheter-Directed Thrombolysis
10. FDA Approves PRISTIQ(TM) for the Treatment of Adult Patients with Major Depressive Disorder
11. AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Major Depressive Disorder

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)..., , SINGAPORE, Dec. 2 /PRNewswire/ ...s on its novel oral JAK2 inhibitor, SB1518, at The...g and Exposition in New Orleans. ,, Data will b... 1 dose-escalation trial of SB1518 detailing its s...namic (PK/PD) profile in dose levels ranging from ...
(Date:12/2/2009)..., , NANJING, China, Dec. 2 /PRNews...re" or the "Company") (NYSE: SCR ), a leading ph...nt, manufacturing, and marketing of branded,generi...announced that 105 of,its drugs have been included...L"), which was issued by China,s Ministry of Human...
(Date:12/2/2009)..., , SHANGHAI, Dec. 2 /PRNewswire-A...imes; markets are in turmoil and uncertainty is pa... that the pharma industry has been,relatively immu...,t take a,vacation. , During the midst of...,giant Johnson & Johnson inaugurated an R&...
(Date:12/2/2009)..., , HOBOKEN, N.J., Dec. 2 /PRNewswire/ -...0 percent to 45 percent of Americans diagnosed wit...inopathy. Diabetic retinopathy, damage to the ret...e of blindness in people with diabetes and is one ...t, up to 80 percent of all patients who,ve had dia...
Breaking Biology Technology:S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 2Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 4
...the leading provider of revenue cycle management f...IFIN,s CEO and Executive Chairman, Lale White, wil... New Orleans on April 28th 2009. In attendance wil...and pathologists from many of the nation,s largest...w.newscom.com/cgi-bin/prnh/20081013/LAM046LOGO ) ,...
...gin after markets close at 2:00 p.m. PT (5:00 p.m....tion (Nasdaq: MASI ), the inventor of Pulse CO-O...on pulse oximetry, today announced it will release...od ended April 4, 2009 after the market closes on ...view the results will begin at 2:00 p.m. PT (5:00 ...
...utical Institute (PI), the leading provider of spe... and biotech industry, today announced the release...s Excellence(TM) . The series was developed follo...enior training leaders from 17 large and midsize p...und that managed markets knowledge emerged as a to...
Other Biology Technology:XIFIN Inc. CEO to Speak at Executive War College Conference 2XIFIN Inc. CEO to Speak at Executive War College Conference 3Masimo to Report First Quarter 2009 Financial Results on May 5, 2009 2Masimo to Report First Quarter 2009 Financial Results on May 5, 2009 3Pharmaceutical Institute Launches New Training Series Focused on Managed Markets Excellence 2Pharmaceutical Institute Launches New Training Series Focused on Managed Markets Excellence 3
(Date:12/2/2009)...uke University Medical Center researchers have fig...cer glioma may be better able to resist radiation ...gnaling pathway in these cancer stem cells, they w...tion in a laboratory experiment. , The work bui...stem cells resist the effects of radiation much be...
(Date:12/2/2009)...e reporting the first identification of substances...at changes harmless marine bacteria into killers t...n ACS, Environmental Science & Technology , a sem...note that bleaching already has destroyed up to 30...s are searching for ways to slow or stop the damag...
(Date:12/2/2009)...ecember 2, 2009 Commonly prescribed beta 2 adrene...pregnant women as well as pre-term labor may incre...ychiatric pathology, cognitive problems and poor s...a new study published in the December 2009 issue o... . , Beta 2 adrenergic agonist drugs as a class ...
Breaking Biology News(10 mins):Discovery makes brain tumor cells more responsive to radiation 2Treatments for asthma and pre-term labor may increase risk of autism in developing fetus 2Worlds largest ocean observatory takes shape 9179 1Worlds largest ocean observatory takes shape 9179 2Worlds largest ocean observatory takes shape 9179 3The Hispanic got milk 3F Campaign Visits Chicago from July 2 July 10 51122 1The Hispanic got milk 3F Campaign Visits Chicago from July 2 July 10 51122 2Global AIDS Alliance Calls on President Obama to Honor His Campaign Promises on Global AIDS and Education 51117 1Global AIDS Alliance Calls on President Obama to Honor His Campaign Promises on Global AIDS and Education 51117 2Global AIDS Alliance Calls on President Obama to Honor His Campaign Promises on Global AIDS and Education 51117 3
...r at the University at Buffalo’s Research Institut...s own marijuana?-- called endocannabinoid -- in th...d anxiety. , A five-year, $1.7 million grant from ...ing this investigation. , “It is widely accepted... abuse marijuana is to relieve stress,?according t...
...dopamine generators (dopaminergics) in brain cells...nson,s, according to the results of tests carried ...l, led by Dr María Rosario Luquin Piudo, neurologi...sity-based medical centre, CIMA (the Research Cent...published in the latest issue of the British scien...
...have found hundreds of new marine creatures in the...ivorous sponges, free-swimming worms, crustaceans,...w insights into the evolution of ocean life. , Rep... describe how creatures in the deeper parts of the...water in the world ocean ?are likely to be related...
Other Biology News:Implanting dopamine generators in brain cells obtains improvement in Parkinson's in monkeys 2Implanting dopamine generators in brain cells obtains improvement in Parkinson's in monkeys 3Scientists discover new life in the Antarctic deep sea 2
...using Mo Bio luciferase assay. Mo Bio Laboratorie... service that will allow you to certify your produ...ble you to deliver them to your customers in a tim...10-12 /l, which will allow you to directly compete...
Mouse Anti-Glucagon-like peptide-1 (GLP-1 (1-36) amide) Monoclonal Antibody, Unconjugated, Clone 9F8 from AntibodyShop A/S
...ys: Biomedical Photometrics Inc. (Waterloo, Ontari...na, Germany) have collaborated to develop a fluore...m. The DNAscope AT is based on BPIs patented MACR...ly reads up to six ArrayTubes in sequence using a ...
...n in Early Drug Development with Imaging Mass Spec...ion data in early drug development using mass spec...etry service maps unlabeled ions and aligns them...s and metabolites prior to synthesizing radiolabel...
Biology Products: